For citations:
Fateeva A.V., Eliseeva E.V., Vdovenko A.V., Komissarova V.A., Zukov R.A., Ponomarenko D.M., Rossokha E.I., Ryabova L.M. Pharmacodynamic approach to assessing leukopenia as a marker of treatment efficacy in CDK4/6 inhibitor therapy in patients with HR+/HER2- metastatic breast cancer: a multicenter real-world study. Real-World Data & Evidence. 2025;5(3):38-46. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-081. EDN: ROYKWG
Email this article 
Post a Comment 